Skip to content
The Nexus
HEALTHMay 26 · 20:22 UTCTHE HILLJoseph Choi

FDA advisers to weigh updated COVID vaccine targeting XFG subvariant

The FDA's Vaccines and Related Biological Products Advisory Committee (VRBPAC) will meet to discuss updating the COVID-19 vaccine to target the XFG subvariant for the 2026-2027 respiratory season. The meeting aims to determine whether current vaccines should be modified to address this emerging variant.

Nexus surfaces and summarizes. The full story lives at the source.

Mentioned
Food and Drug AdministrationorganizationVaccines and Related Biological Products Advisory CommitteeorganizationXFG subvarianttopicCOVID-19 vaccinetopic2026-2027 respiratory viral seasontopic
Spot something wrong with this article?Report a problem →
Forward this